Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
Fiona Lee, PharmD Candidate
Advertisement
Articles by Fiona Lee, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: CVS Buys Rite Aid, Bartell Drugs
2
FDA Approves 1-Minute HIV Self-Test
3
Young Women With Symptomatic Long COVID At Higher Risk of POTS
4
Statins and Metformin Improved Survival in Patients With Triple-Negative Breast Cancer
5
